| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-2607-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-50445-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-61927-25ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-2776-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52639-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-54628-0.025mg | |||
![Western Blot: Synaptojanin 1 Antibody (5H1) [NBP1-47559] - Rat Hippocampal Lysate showing specific immunolabeling of the ~145k Synaptojanin protein.](http://images.novusbio.com/fullsize/Synaptojanin-1-Antibody-5H1-Western-Blot-NBP1-47559-img0001.jpg "Western Blot: Synaptojanin 1 Antibody (5H1) [NBP1-47559] - Rat Hippocampal Lysate showing specific immunolabeling of the ~145k Synaptojanin protein.")
![Western Blot: Troponin I Type 3 (cardiac) [p Ser43] Antibody [NBP2-29515] - Western blot of mouse heart lysate showing specific immunolabeling of the ~25k cTnI protein phosphorylated at Ser43 (control). Phosphospecificity is shown in the second lane. The blot is identical to the control except that the lysate was incubated in lambda-Ptase (1400 units for 30 min). The immunolabeling is greatly decreased by treatment with lambda-Ptase.](http://images.novusbio.com/fullsize/Troponin-I-Type-3-cardiac-p-Ser43-Antibody-Western-Blot-NBP2-29515-img0001.jpg "Western Blot: Troponin I Type 3 (cardiac) [p Ser43] Antibody [NBP2-29515] - Western blot of mouse heart lysate showing specific immunolabeling of the ~25k cTnI protein phosphorylated at Ser43 (control). Phosphospecificity is shown in the second lane. The blot is identical to the control except that the lysate was incubated in lambda-Ptase (1400 units for 30 min). The immunolabeling is greatly decreased by treatment with lambda-Ptase.")
![Western Blot: RLBP1L1 Antibody [NBP2-29652] - rat hippocampal homogenate showing specific immunolabeling of the ~ 35k clavesin protein.](http://images.novusbio.com/fullsize/RLBP1L1-Antibody-Western-Blot-NBP2-29652-img0001.jpg "Western Blot: RLBP1L1 Antibody [NBP2-29652] - rat hippocampal homogenate showing specific immunolabeling of the ~ 35k clavesin protein.")
![Flow Cytometry: CD4 Antibody (3-4F4) [NBP1-28258] - Cat phenotyping. The whole blood cells from the cat were washed and incubated at 4degree with the antibody. It helped characterize Tcell population in the species.This image was submitted via customer review. Image from the Allophycocyanin version of this antibody.](http://images.novusbio.com/fullsize/CD4-Antibody-3-4F4-Flow-Cytometry-NBP1-28258-img0004.jpg "Flow Cytometry: CD4 Antibody (3-4F4) [NBP1-28258] - Cat phenotyping. The whole blood cells from the cat were washed and incubated at 4degree with the antibody. It helped characterize Tcell population in the species.This image was submitted via customer review. Image from the Allophycocyanin version of this antibody.")
![Flow Cytometry: CD4 Antibody (3-4F4) [NBP1-28258] - Analysis using the FITC conjugate of NBP1-28258. Multiple staining of peripheral lymphocytes.](http://images.novusbio.com/fullsize/CD4-Antibody-3-4F4-Flow-Cytometry-NBP1-28258-img0002.jpg)
![Flow Cytometry: CD4 Antibody (3-4F4) [NBP1-28258] - Analysis using the FITC conjugate of NBP1-28258. Double staining of 1 ug/10^6 Peripheral blood mononuclear cells from a healthy domestic cat with mouse anti-feline CD4-FITC and mouse anti-feline CD8-R-PE.](http://images.novusbio.com/fullsize/CD4-Antibody-3-4F4-Flow-Cytometry-NBP1-28258-img0003.jpg)
![Western Blot: KDEL Antibody (2D6) [NBP2-61927] - Western Blot analysis of Human Cervical cancer cell line (HeLa) lysate showing detection of Multiple KDEL protein using Mouse Anti-KDEL Monoclonal Antibody, Clone 2D6 (NBP2-61927). Lane 1: Molecular Weight Ladder (MW). Lane 2: Anti-KDEL (NBP2-61927). Lane 3: Anti-KDEL control (SPC-109). Lane 4: Anti-PDI control (SPC-114). Lane 5: Anti-Calreticulin control (SPC-122). Lane 6: Anti-GRP78 control (SPC-107). Lane 7: Anti-GRP94 control (SPC-101).. Load: 10 ug. Block: 5% Skim Milk powder in TBST. Primary Antibody: Mouse Anti-KDEL Monoclonal Antibody (NBP2-61927) at 1:1000 for 2 hours at RT. Secondary Antibody: Goat Anti-Mouse IgG:HRP at 1:5000 for 1 hour at RT. Color Development: ECL solution for 5 min in RT. Predicted/Observed Size: Multiple.](http://images.novusbio.com/fullsize/KDEL-Antibody-2D6-Western-Blot-NBP2-61927-img0002.jpg "Western Blot: KDEL Antibody (2D6) [NBP2-61927] - Western Blot analysis of Human Cervical cancer cell line (HeLa) lysate showing detection of Multiple KDEL protein using Mouse Anti-KDEL Monoclonal Antibody, Clone 2D6 (NBP2-61927). Lane 1: Molecular Weight Ladder (MW). Lane 2: Anti-KDEL (NBP2-61927). Lane 3: Anti-KDEL control (SPC-109). Lane 4: Anti-PDI control (SPC-114). Lane 5: Anti-Calreticulin control (SPC-122). Lane 6: Anti-GRP78 control (SPC-107). Lane 7: Anti-GRP94 control (SPC-101).. Load: 10 ug. Block: 5% Skim Milk powder in TBST. Primary Antibody: Mouse Anti-KDEL Monoclonal Antibody (NBP2-61927) at 1:1000 for 2 hours at RT. Secondary Antibody: Goat Anti-Mouse IgG:HRP at 1:5000 for 1 hour at RT. Color Development: ECL solution for 5 min in RT. Predicted/Observed Size: Multiple.")
![Immunohistochemistry-Paraffin: ErbB2/Her2 Antibody (4D5-8 (trastuzumab)) - Chimeric [NBP2-52639] - Immunohistochemical Anti-erbB-2 (Her-2/neu) staining of paraffin embedded human breast tissue using the rabbit-chimeric version of 4D5-8 (trastuzumab) (NBP2-52639). Primary antibody incubation with NBP2-52639 was carried out at 4 ug/ml for 30 minutes. Samples were then incubated with an anti-rabbit IgG HRP secondary antibody for 20 mins followed by DAB (3,3'-diaminobenzidine), and counter-staining with haemotoxylin. Weak membrane staining exclusively of ductal epithelial cells may be observed. Recommended concentration, 4-6 ug/ml.](http://images.novusbio.com/fullsize/ErbB2-Her2-Antibody-4D5-8-trastuzumab-Chimeric-Immunohistochemistry-Paraffin-NBP2-52639-img0001.jpg "Immunohistochemistry-Paraffin: ErbB2/Her2 Antibody (4D5-8 (trastuzumab)) - Chimeric [NBP2-52639] - Immunohistochemical Anti-erbB-2 (Her-2/neu) staining of paraffin embedded human breast tissue using the rabbit-chimeric version of 4D5-8 (trastuzumab) (NBP2-52639). Primary antibody incubation with NBP2-52639 was carried out at 4 ug/ml for 30 minutes. Samples were then incubated with an anti-rabbit IgG HRP secondary antibody for 20 mins followed by DAB (3,3'-diaminobenzidine), and counter-staining with haemotoxylin. Weak membrane staining exclusively of ductal epithelial cells may be observed. Recommended concentration, 4-6 ug/ml.")